Pathstone Holdings
ABBV icon

Pathstone Holdings’s AbbVie ABBV Stock Holding History

Pathstone Holdings’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$75.1M Buy
298,011
+50,501
+20% +$10.9M 0.22% 75
2026
Q1 		$53.8M Buy
247,510
+9,618
+4% +$2.13M 0.21% 72
2025
Q4 		$54.4M Buy
237,892
+6,345
+3% +$1.45M 0.21% 71
2025
Q3 		$53.6M Buy
231,547
+5,793
+3% +$1.18M 0.2% 71
2025
Q2 		$41.9M Sell
225,754
-19,927
-8% -$3.7M 0.17% 83
2025
Q1 		$51.5M Buy
245,681
+5,105
+2% +$992K 0.22% 75
2024
Q4 		$42.7M Sell
240,576
-1,787
-0.7% -$329K 0.19% 81
2024
Q3 		$47.9M Sell
242,363
-2,594
-1% -$484K 0.21% 81
2024
Q2 		$42M Sell
244,957
-1,049
-0.4% -$174K 0.19% 84
2024
Q1 		$44.8M Sell
246,006
-3,487
-1% -$601K 0.21% 75
2023
Q4 		$38.7M Buy
+249,493
New +$36.4M 0.21% 78

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Pathstone Holdings's ABBV Position: Q2 2026 in Review

Pathstone Holdings increased its AbbVie (ABBV) stake by 20% in Q2 2026, buying an estimated $10.9M and bringing the position to 298,011 shares worth $75.1M. The position accounts for 0.22% of the portfolio, ranked #75.

Pathstone Holdings first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Pathstone Holdings held 298,011 shares of AbbVie worth $75.1M as of Q2 2026.
  • Pathstone Holdings bought 50,501 AbbVie shares in Q2 2026, an estimated $10.9M.
  • AbbVie made up 0.22% of Pathstone Holdings's portfolio in Q2 2026, its #75 holding.
  • Pathstone Holdings first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.